Task: Answer Verification
Input (English): Question: Are the cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease modified by mild to moderate renal insufficiency : insights from the EUROPA trial?
Answer: The treatment benefit of perindopril is consistent and not modified by mild to moderate renal insufficiency.
Output (English): no